Propafenone efficacy in treatment of atrial fibrillation paroxysms: a placebo-controlled study
In a placebo-controlled study, propafenone efficacy and safety for pharmaceutical cardioversion in atrial fibrillation (AF) paroxysms were studied. The study included 50 patients aged 28-69 years (mean age 53,9+9,7), with AF paroxysms lasting for less than 48 hours. Participants were randomized to p...
I tiakina i:
| Ngā kaituhi matua: | , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Russo |
| I whakaputaina: |
«FIRMA «SILICEA» LLC
2005-12-01
|
| Rangatū: | Российский кардиологический журнал |
| Ngā marau: | |
| Urunga tuihono: | https://russjcardiol.elpub.ru/jour/article/view/2343 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|